Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.38 USD | -4.29% | +15.17% | +13.91% |
05-03 | Stifel Starts Phathom Pharmaceuticals With Buy Rating, $24 Price Target | MT |
03-07 | Transcript : Phathom Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.91% | 634M | |
+20.17% | 46.81B | |
-1.05% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.69% | 26.06B | |
-19.76% | 19.13B | |
+32.35% | 12.39B | |
+0.30% | 12.08B | |
-0.60% | 11.96B |
- Stock Market
- Equities
- PHAT Stock
- News Phathom Pharmaceuticals, Inc.
- Earnings Flash (PHAT) PHATHOM PHARMACEUTICALS Posts Q3 Loss $-0.98